ASLAN Pharmaceuticals Limited (ASLN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 17.19M |
| Enterprise Value | 22.76M |
| P/E Ratio | -0.06 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 64.76 |
| Price/Book Ratio | -0.19 |
| Enterprise/Revenue | 65.22 |
| Enterprise/EBITDA | -19.86 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | March 31, 2024 |
| Profit Margin | -3.68 |
| Operating Margin | -3.64 |
| Return On Assets | -1.8 |
| Return On Equity | 17.97 |
| Revenue | 12M |
| Revenue/Share | 2.92 |
| Gross Profit | 11.65M |
| EBITDA | -39.4M |
| Net Income | -44.22M |
| Diluted EPS | -10.76 |
| Total Cash | 18.4M |
| Total Cash/Share | 5.17 |
| Total Debt | 26.67M |
| Total Debt/Equity | -2.02 |
| Current Ratio | 1.84 |
| Book Value Per Share | -3.23 |
| 52-Week Change | -96.51 |
| 52-Week High | 17.04 |
| 52-Week Low | 0.48 |
| Moving Average 50 Days | 1.07 |
| Moving Average 200 Days | 3.48 |
| Average Volume | 102,493 |
| Shares Outstanding | 1.3B |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | July 03, 2024 |